Back to Department of Radiation Oncology
Radiation Oncology Research
It's All Translational
That conviction drives the research in our Cancer Biology, Molecular Imaging and Physics Divisions as well as in the Clinical Division where the most obvious translation occurs.
Our scientists believe that their work in genomics or metabolomics or cancer cell biology is as much about improving cancer therapy as are quality of life studies and testing of new combination therapies or novel agents. Our physicists have been and continue to be leaders in the development of various imaging techniques to advance treatment planning and ever more precise delivery radiation therapy.
Our Initiatives
Featured News & Stories
Health Lab
Doctors treat lung cancer patient after cancer metastasized to her brain
Linda Rossi was initially diagnosed with lung cancer and moved to Michigan for treatment from U-M. She received surgery, but four years later the tumor spread to her brain, and she was treated with surgery and radiation.
Health Lab
Radiation therapy for non-cancer diseases
An expert discusses the long time usage of radiation therapy for non-cancer diseases in other countries that are now available in the United States.
Health Lab
7-year-old faces cancer treatment with ‘optimistic sassiness’
Emilia Pigeon was diagnosed with neuroblastoma, a type of cancer that starts in immature nerve cells. She was treated with chemotherapy and surgery and continues to do well.
Health Lab
Dietary changes could provide a therapeutic avenue for brain cancer
A team of researchers from Michigan Medicine tracked how glucose is used in glioblastoma tumor cells. They showed that dietary interventions can slow brain cancer growth in mice.
Health Lab
Brain cancer patient finds a way forward
Sidney Ritchie’s aggressive brain cancer diagnosis has changed her life, and now, in her new reality, she finds meaning and purpose through connection, volunteering, and “showing up fully”
Cancer Aware
University of Michigan’s Impact on the Future of Cancer Care
Four University of Michigan faculty members have served as president of the American Society of Clinical Oncology, a rare distinction that only two other institutions can claim. ASCO is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.
In this episode, Nicole Fawcett, director of communications for the Rogel Cancer Center, sat down with four past ASCO Presidents and talked about the importance of the society, the impact it has had on cancer care and research as a whole and the impact here at U-M.
Participants:
Allen Lichter, MD, FASTRO
Doug Blayney, MD
Dan Hayes, MD
Lori Pierce, MD
